Invesco Biotechnology & Genome ETF

PBE
$83.51 (- $0.74 - 0.88%)
Last updated: 2026-06-10 21:01 UTC
PBE Metrics
Exchange
🇺🇸 NYSE ARCX
NYSE ArcaUnited StatesAmerica/New_York
SectorHealth
IndustryInvesco
ISINUS46137V7872
CUSIP46137V787
Market Price83.51
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyYearly
P/E Ratio20.07
EPS4.19
Market Cap$382.9M
Book Value75.35
Price to Book1.117
BetaN/A
52w High84.16
52w Low54.52
Next Earnings DateN/A

Invesco Biotechnology & Genome ETF trades under ticker PBE on NYSE as an ETF. Use this page to review its stock price, dividends, and price history. The page also shows Health exposure. Identifiers: ISIN US46137V7872, CUSIP 46137V787.

About the Company
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
Price History